Literature DB >> 22793942

The importance of the assessment of pulmonary function in COPD.

Kristina L Bailey1.   

Abstract

Spirometry is the gold standard for making the diagnosis of COPD. It should be performed in every case of suspected COPD. Other pulmonary functions, such as lung volumes, can give insight into physiologic consequences of COPD, such as hyperinflation. Pulmonary function testing can also aid in assessing the severity of disease and in managing the disease after diagnosis is made.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22793942      PMCID： PMC3998207          DOI： 10.1016/j.mcna.2012.04.011

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


  18 in total

1.  Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994.

Authors:  D M Mannino; R C Gagnon; T L Petty; E Lydick
Journal:  Arch Intern Med       Date:  2000-06-12

2.  Impact of spirometry on GPs' diagnostic differentiation and decision-making.

Authors:  Niels Chavannes; Tjard Schermer; Reinier Akkermans; J E Jacobs; Gabrielle van de Graaf; Ralf Bollen; Onno van Schayck; Ben Bottema
Journal:  Respir Med       Date:  2004-11       Impact factor: 3.415

3.  Should FEV1/FEV6 replace FEV1/FVC ratio to detect airway obstruction? A metaanalysis.

Authors:  Ji-Yong Jing; Tian-Cha Huang; Wei Cui; Feng Xu; Hua-Hao Shen
Journal:  Chest       Date:  2009-04       Impact factor: 9.410

4.  Effect of primary-care spirometry on the diagnosis and management of COPD.

Authors:  P P Walker; P Mitchell; F Diamantea; C J Warburton; L Davies
Journal:  Eur Respir J       Date:  2006-07-26       Impact factor: 16.671

Review 5.  Use of spirometry in the diagnosis of chronic obstructive pulmonary disease and efforts to improve quality of care.

Authors:  Min J Joo; David H Au; Todd A Lee
Journal:  Transl Res       Date:  2009-07-08       Impact factor: 7.012

6.  The diffusing capacity as a predictor of arterial oxygen desaturation during exercise in patients with chronic obstructive pulmonary disease.

Authors:  G R Owens; R M Rogers; B E Pennock; D Levin
Journal:  N Engl J Med       Date:  1984-05-10       Impact factor: 91.245

7.  Patient-reported dyspnea in COPD reliability and association with stage of disease.

Authors:  Donald A Mahler; Joseph Ward; Laurie A Waterman; Corliss McCusker; Richard ZuWallack; John C Baird
Journal:  Chest       Date:  2009-08-20       Impact factor: 9.410

8.  Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers.

Authors:  J A Hardie; A S Buist; W M Vollmer; I Ellingsen; P S Bakke; O Mørkve
Journal:  Eur Respir J       Date:  2002-11       Impact factor: 16.671

9.  Prognosis in chronic obstructive pulmonary disease.

Authors:  N R Anthonisen; E C Wright; J E Hodgkin
Journal:  Am Rev Respir Dis       Date:  1986-01

10.  Severity staging of chronic obstructive pulmonary disease: differences in pre- and post-bronchodilator spirometry.

Authors:  Sheng-Hsiang Lin; Ping-Hung Kuo; Sow-Hsong Kuo; Pan-Chyr Yang
Journal:  Yonsei Med J       Date:  2009-10-21       Impact factor: 2.759
View more
  9 in total

1.  Outpatient Management of Chronic Obstructive Pulmonary Disease: Physician Adherence to the 2017 Global Initiative for Chronic Obstructive Lung Disease Guidelines and its Effect on Patient Outcomes.

Authors:  Brian Chinai; Krystal Hunter; Satyajeet Roy
Journal:  J Clin Med Res       Date:  2019-07-27

2.  Approaches to the assessment of severe asthma: barriers and strategies.

Authors:  Eleanor C Majellano; Vanessa L Clark; Natasha A Winter; Peter G Gibson; Vanessa M McDonald
Journal:  J Asthma Allergy       Date:  2019-08-23

3.  Lower DLco% identifies exercise pulmonary hypertension in patients with parenchymal lung disease referred for dyspnea.

Authors:  Richard H Zou; William D Wallace; S Mehdi Nouraie; Stephen Y Chan; Michael G Risbano
Journal:  Pulm Circ       Date:  2020-02-19       Impact factor: 3.017

4.  Downregulation of epithelial DUOX1 in chronic obstructive pulmonary disease.

Authors:  Caspar Schiffers; Cheryl van de Wetering; Robert A Bauer; Aida Habibovic; Milena Hristova; Christopher M Dustin; Sara Lambrichts; Pamela M Vacek; Emiel Fm Wouters; Niki L Reynaert; Albert van der Vliet
Journal:  JCI Insight       Date:  2021-01-25

Review 5.  Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide.

Authors:  Agustín Roberto García; Lucilla Piccari
Journal:  Curr Opin Pulm Med       Date:  2022-07-16       Impact factor: 2.868

Review 6.  Tocotrienols: Dietary Supplements for Chronic Obstructive Pulmonary Disease.

Authors:  Xiangming Ji; Hongwei Yao; Maureen Meister; Douglas S Gardenhire; Huanbiao Mo
Journal:  Antioxidants (Basel)       Date:  2021-05-31

7.  Relationship of spirometric, body plethysmographic, and diffusing capacity parameters to emphysema scores derived from CT scans.

Authors:  Kathrin Kahnert; Bertram Jobst; Frank Biertz; Jürgen Biederer; Henrik Watz; Rudolf M Huber; Jürgen Behr; Philippe A Grenier; Peter Alter; Claus F Vogelmeier; Hans-Ulrich Kauczor; Rudolf A Jörres
Journal:  Chron Respir Dis       Date:  2018-05-09       Impact factor: 2.444

8.  The rat model of COPD skeletal muscle dysfunction induced by progressive cigarette smoke exposure: a pilot study.

Authors:  Jianqing Su; Jian Li; Yufan Lu; Ning Li; Peijun Li; Zhengrong Wang; Weibing Wu; Xiaodan Liu
Journal:  BMC Pulm Med       Date:  2020-03-23       Impact factor: 3.317

9.  Implications of using the GLI-2012, GOLD and Australian COPD-X recommendations in assessing the severity of airflow limitation on spirometry among an Indigenous population with COPD: an Indigenous Australians perspective study.

Authors:  Subash Heraganahally; Timothy P Howarth; Elisha White; Helmi Ben Saad
Journal:  BMJ Open Respir Res       Date:  2021-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.